Publication:
Narrowband UVB (311 nm, TL01) phototherapy for pityriasis lichenoides

Simple item page
dc.contributor.buuauthorAydoğan, Kenan
dc.contributor.buuauthorSarıcaoğlu, Hayriye
dc.contributor.buuauthorTuran, Hakan
dc.contributor.departmentTıp Fakültesi
dc.contributor.departmentDermatoloji Ana Bilim Dalı
dc.contributor.orcid0000-0002-0193-1128
dc.contributor.researcheridAAH-6216-2021
dc.contributor.scopusid9739755800
dc.contributor.scopusid6603722836
dc.contributor.scopusid16835681500
dc.date.accessioned2022-01-12T12:51:08Z
dc.date.available2022-01-12T12:51:08Z
dc.date.issued2008-06
dc.description.abstractBackground/purpose: Narrowband (NB) UVB (NB-UVB) phototherapy has recently demonstrated high levels of efficacy and tolerability in a variety of skin diseases. The purpose of the present study was to assess the efficacy of NB-UVB phototherapy in the management of pityriasis lichenoides (PL). Methods: The therapeutic response in 31 PL patients (23 pityriasis lichenoides et varioliformis acuta; PLEVA, eight pityriasis lichenoides chronica; PLC) treated with NB-UVB phototherapy between 2000 and 2007 was assessed. Results:NB-UVB treatment led to a complete response (CR) in 15 out of 23 PLEVA patients (65.2%) with a mean cumulative dose of 23 J/cm(2) after a mean number of 43.4 exposures and a partial response (PR) in eight patients (34.8%) with a cumulative dose of 15.6 J/cm(2) after a mean number of 32.3 exposures. NB-UVB treatment led to CR in seven out of eight PLC patients (87.5%) with a mean cumulative dose of 18.4 J/cm(2) after a mean number of 45.8 exposures and PR in one patient (12.5%) with a cumulative dose of 9.1 J/cm(2) after a mean number of 19 exposures. Relapses occurred in four PL patients within a mean time period of 6 months. Conclusion: NB-UVB therapy is an effective, safe and practical alternative treatment modality for the management of PLEVA and PLC.
dc.identifier.citationAydoğan, K. vd. (2008). "Narrowband UVB (311 nm, TL01) phototherapy for pityriasis lichenoides". Photodermatology Photoimmunology and Photomedicine, 24(3), 128-133.
dc.identifier.endpage133
dc.identifier.issn0905-4383
dc.identifier.issn1600-0781
dc.identifier.issue3
dc.identifier.pubmed18477131
dc.identifier.scopus2-s2.0-43649099550
dc.identifier.startpage128
dc.identifier.urihttps://doi.org/10.1111/j.1600-0781.2008.00350.x
dc.identifier.urihttps://onlinelibrary.wiley.com/doi/10.1111/j.1600-0781.2008.00350.x
dc.identifier.urihttp://hdl.handle.net/11452/24047
dc.identifier.volume24
dc.identifier.wos000255836100004
dc.indexed.wosSCIE
dc.language.isoen
dc.publisherWiley
dc.relation.journalPhotodermatology Photoimmunology and Photomedicine
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectNarrowband UVB phototherapy
dc.subjectPityriasis lichenoides
dc.subjectVarioliformis-acuta
dc.subjectUltraviolet-radiation
dc.subjectIrradiation
dc.subjectExpression
dc.subjectTherapy
dc.subjectLight
dc.subjectDermatology
dc.subject.emtreeAntibiotic agent
dc.subject.emtreeMethotrexate
dc.subject.emtreePsoralen
dc.subject.emtreeSteroid
dc.subject.emtreeAdolescent
dc.subject.emtreeAdult
dc.subject.emtreeAged
dc.subject.emtreeArticle
dc.subject.emtreeClinical article
dc.subject.emtreeClinical effectiveness
dc.subject.emtreeControlled study
dc.subject.emtreeDisease severity
dc.subject.emtreeErythema
dc.subject.emtreeFemale
dc.subject.emtreeHuman
dc.subject.emtreeMale
dc.subject.emtreePatient safety
dc.subject.emtreePityriasis lichenoides
dc.subject.emtreePriority journal
dc.subject.emtreePUVA
dc.subject.emtreeRadiation dose
dc.subject.emtreeRadiation exposure
dc.subject.emtreeRelapse
dc.subject.emtreeSchool child
dc.subject.emtreeTreatment response
dc.subject.emtreeUltraviolet b radiation
dc.subject.emtreeChild
dc.subject.emtreeMethodology
dc.subject.emtreeMiddle aged
dc.subject.emtreePhototherapy
dc.subject.emtreePityriasis lichenoides
dc.subject.emtreeRecurrent disease
dc.subject.emtreeRemission
dc.subject.emtreeRetrospective study
dc.subject.emtreeTreatment outcome
dc.subject.meshAdolescent
dc.subject.meshAdult
dc.subject.meshAged
dc.subject.meshChild
dc.subject.meshFemale
dc.subject.meshHumans
dc.subject.meshMale
dc.subject.meshMiddle aged
dc.subject.meshPityriasis lichenoides
dc.subject.meshRadiation dosage
dc.subject.meshRecurrence
dc.subject.meshRemission induction
dc.subject.meshRetrospective studies
dc.subject.meshTreatment outcome
dc.subject.meshUltraviolet therapy
dc.subject.scopusPityriasis Lichenoides; Febrile Ulceronecrotic Mucha-Habermann Disease; Lymphomatoid Papulosis
dc.subject.wosDermatology
dc.titleNarrowband UVB (311 nm, TL01) phototherapy for pityriasis lichenoides
dc.typeArticle
dc.wos.quartileQ3
dspace.entity.typePublication
local.contributor.departmentTıp Fakültesi/Dermatoloji Ana Bilim Dalı
local.indexed.atScopus
local.indexed.atWOS

Files

License bundle

Now showing 1 - 1 of 1
Placeholder
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

İndeksli Yayınlar / Indexed Publications